Robert E. Conway, Director at ARCA biopharma, Inc. (ABIO), bought 10,000 shares at $3.19 ($32K) on 2021-05-12, disclosed to the SEC on 2021-05-13.
Open-market purchase of $32k ABIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ALPN | BUY | 2021-09-23 | $98K | — | Filing → |
| ABIO | BUY | 2021-05-06 | $32K | — | Filing → |
| ABIO | BUY | 2020-12-21 | $42K | — | Filing → |